Skip to content

Immuneering Corp

IMRX Nasdaq SEC CIK 1790340

Follow Immuneering Weekly email: filings, results, news

News

1 story filed under Immuneering

H.C. Wainwright reiterates Immuneering stock rating on MEK pathway potential

Markets 28 d ago

Profile

Headquarters: CAMBRIDGE, MA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 1 story clustered from the RSS aggregator